相关实验视频

Updated: Jun 25, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

7.9K

通过组织学转变从非小细胞肺癌到癌瘤的Osimertinib抵抗

Paul Stegelmeier1, James A Dawson1, McKenzie Wallace2

  • 1Department of Pathology and Anatomical Sciences, A.T. Still University Kirksville College of Osteopathic Medicine, Kirksville, USA.

Cureus
|May 30, 2024
PubMed
概括

一个罕见的非小细胞肺癌 (NSCLC) 在 osimertinib 治疗期间转化为癌瘤的病例突显出一种新的耐药性机制. 这种组织学转变带来了重大挑战,需要进一步研究晚期肺癌的新疗法策略.

关键词:
组织学转换转变非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.奥西米尔丁尼布 (osimertinib) 是一种奥西默蒂尼布的耐药性是异常的肺癌类肉瘤 (pcs) 肺癌类肉瘤 (pcs)氨酸激酶抑制剂 (tki) 的使用

更多相关视频

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.8K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.0K

相关概念视频

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K